1. He, Songlin, Gao, Ke, Mao, Long, Bhushan, Sandeep, Xiao, Zongwei. 2020. Gene Silencing of Transcription Factor TEAD4 Inhibits Esophageal Cancer Cells by Regulating TCF7. In Cancer biotherapy & radiopharmaceuticals, 38, 132-139. doi:10.1089/cbr.2020.3870. https://pubmed.ncbi.nlm.nih.gov/32822226/
2. Wang, Ya-Qin, Wu, Dong-Hong, Wei, Denghui, Lv, Jiawei, Chen, Yu-Pei. 2023. TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. In Science advances, 9, eadd0960. doi:10.1126/sciadv.add0960. https://pubmed.ncbi.nlm.nih.gov/36608137/
3. Chi, Ming, Liu, Jiao, Mei, Chenxue, Meng, Xin, Wang, Biao. 2022. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. In Journal of experimental & clinical cancer research : CR, 41, 175. doi:10.1186/s13046-022-02377-3. https://pubmed.ncbi.nlm.nih.gov/35581606/
4. Cai, Jingwei, Chen, Tianyi, Jiang, Zhiyu, Xu, Junjie, Cai, Xiujun. 2023. Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma. In International journal of biological sciences, 19, 2114-2131. doi:10.7150/ijbs.82177. https://pubmed.ncbi.nlm.nih.gov/37151879/
5. Dos Santos, Matthieu, Shah, Akansha M, Zhang, Yichi, Liu, Ning, Olson, Eric N. 2023. Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolution. In Nature communications, 14, 4333. doi:10.1038/s41467-023-40073-8. https://pubmed.ncbi.nlm.nih.gov/37468485/
6. Hsu, Sheng-Chieh, Lin, Ching-Yu, Lin, Yen-Yi, Chen, Chia-Lin, Kung, Hsing-Jien. 2022. TEAD4 as an Oncogene and a Mitochondrial Modulator. In Frontiers in cell and developmental biology, 10, 890419. doi:10.3389/fcell.2022.890419. https://pubmed.ncbi.nlm.nih.gov/35602596/